4//SEC Filing
PDL BIOPHARMA, INC. 4
Accession 0000882104-15-000073
CIK 0000882104operating
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 6:54 PM ET
Size
4.9 KB
Accession
0000882104-15-000073
Insider Transaction Report
Form 4
Stone Christopher Lewis
VP and General Counsel
Transactions
- Award
Common stock
2015-09-29$4.95/sh+15,291$75,690→ 155,764 total
Footnotes (1)
- [F1]The restricted stock will vest, provided that the officer remains employed by the Company and certain performance goals are achieved, based upon the following schedule: 50% on December 2016; 16.66% on December 2017; 16.66% on December 2018; and 16.66% on December 2019.
Documents
Issuer
PDL BIOPHARMA, INC.
CIK 0000882104
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000882104
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 6:54 PM ET
- Size
- 4.9 KB